A retrospective analysis of the prevalence of hypophosphatemia and hypocalcemia after intravenous iron polymaltose in the inpatient setting.

ABSTRACT: Hypophosphatemia occurring after ferric carboxymaltose or iron polymaltose infusion is common and has been well-characterized. Post-iron infusion hypocalcemia has been documented in case reports, but there is no data on the prevalence of hypocalcemia developing after i.v. iron infusion. In this retrospective cohort study, we sought to characterize integrated daily changes in serum phosphate and corrected calcium levels before and after iron infusion in a real-world inpatient setting. Inpatients who received i.v. iron polymaltose at the Royal Brisbane and Women's Hospital (Queensland, Australia) between January 2020 and September 2021 were included. We extracted all results for serum phosphate and corrected calcium levels for 21 d before and after iron infusion. A total of 741 patients with

SUBMITTER: Burrage LC 

PROVIDER: S-EPMC12723662 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature